The applications submitted to the ‘Infectious Diseases Catalyst Grants 2026’ will be assessed by the Committee for Infectious Diseases (CID), which was established in 2026 and approved by the Novo Nordisk Foundation Board of Directors to make the granting decisions for this call. The committee will consist of up to seven members with relevant and complementary scientific and translational expertise, with a diverse representation from various, but primarily European, institutions. The committee members are experts within various fields of infectious diseases research, including pandemic influenza and AMR.
Committee for Infectious Diseases (CID)
Professor Florian Krammer
Chair
Icahn School of Medicine at Mount Sinai
Professor Alice McHardy
Member
Helmholtz Centre for Infection Research
Professor Isabella Eckerle
Member
University of Geneva
Professor Luisa Peixe
Member
University of Porto
Professor Mihai Netea
Member
Radboud University
Professor Shampa Das
Member
University of Liverpool
Professor Till Bachmann
Member
University of Edinburgh
